Recent Progress in the Diagnosis and Management of Type 2 Diabetes Mellitus in the Era of COVID-19 and Single Cell Multi-Omics Technologies.

Kupai, Krisztina; Várkonyi, Tamás; Török, Szilvia; Gáti, Viktória; Czimmerer, Zsolt; Puskás, László G; Szebeni, Gábor J

Kupai, Krisztina; Várkonyi, Tamás; Török, Szilvia; Gáti, Viktória; Czimmerer, Zsolt; Puskás, László G; Szebeni, Gábor J.

Afiliação

Kupai K; Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, Közép fasor 52, 6726 Szeged, Hungary.
Várkonyi T; Department of Internal Medicine, University of Szeged, Korányi fasor 8, 6720 Szeged, Hungary.
Török S; Department of Internal Medicine, University of Szeged, Korányi fasor 8, 6720 Szeged, Hungary.
Gáti V; Department of Physiology, Anatomy and Neuroscience, Faculty of Science and Informatics, University of Szeged, Közép fasor 52, 6726 Szeged, Hungary.
Czimmerer Z; Laboratory of Functional Genomics, Biological Research Centre, Temesvári krt. 62, 6726 Szeged, Hungary.
Puskás LG; Laboratory of Functional Genomics, Biological Research Centre, Temesvári krt. 62, 6726 Szeged, Hungary.
Szebeni GJ; Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Life Science Building, Egyetem tér 1, 4032 Debrecen, Hungary.

Life (Basel) ; 12(8)2022 Aug 08.

Article em En | MEDLINE | ID: mdl-36013384

Palavras-chave

COVID-19; CVD risk; inflammation; insulin resistance; obesity; type 2 diabetes mellitus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Revista: Life (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Hungria

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google